dockets
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
268 rows where agency_id = "DEA" and docket_type = "Rulemaking" sorted by last_modified descending
This data as json, CSV (advanced)
Suggested facets: last_modified (date), keywords (array)
| id | agency_id | title | docket_type | last_modified ▲ | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEA-2026-1024 | DEA | Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act (DEA1665) | Rulemaking | 2026-07-01T16:59:26Z | 0b000064b9360f2f | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2026-07-01T16:59:26Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act (DEA1665)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b9360f2f"} | single_get | ||||||||
| DEA_FRDOC_0001 | DEA | Recently Posted DEA Rules and Notices | Rulemaking | 2026-07-01T12:26:04Z | 0b0000648025b551 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2026-07-01T12:26:04Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Recently Posted DEA Rules and Notices", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648025b551"} | single_get | ||||||||
| DEA-2026-0892 | DEA | Schedules of Controlled Substances: Placement of Diphenidine in Schedule I (DEA1155) | Rulemaking | 2026-06-29T15:57:01Z | 0b000064b92f1465 | Not Assigned | The Drug Enforcement Administration proposes placing diphenidine (1-(1,2- diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle or propose to handle diphenidine. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-06-29T15:57:01Z", "dkAbstract": "The Drug Enforcement Administration proposes placing diphenidine (1-(1,2- diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle or propose to handle diphenidine.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Diphenidine in Schedule I (DEA1155)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b92f1465"} | single_get | |||||||
| DEA-2026-0958 | DEA | Schedules of Controlled Substances: Placement of ODesmethyltramadol in Schedule I (DEA1641) | Rulemaking | 2026-06-25T20:58:52Z | 0b000064b934af21 | Not Assigned | The DEA proposes to schedule Odesmethyltramadol (other names: ODSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or p | {"displayProperties": [], "keywords": null, "modifyDate": "2026-06-25T20:58:52Z", "dkAbstract": "The DEA proposes to schedule Odesmethyltramadol (other names: ODSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or p", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of ODesmethyltramadol in Schedule I (DEA1641)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b934af21"} | single_get | |||||||
| DEA-2024-0059 | DEA | Schedules of Controlled Substances: Rescheduling of Marijuana | Rulemaking | 2026-06-24T20:02:18Z | 0b0000648656cd99 | Not Assigned | The Department of Justice is proposing to transfer clinical marijuana from schedule I of the Controlled Substances Act (“CSA”) to schedule III of the CSA, consistent with the view of the Department of Health and Human Services (“HHS”) that marijuana has a currently accepted medical use as well as HHS’s views about marijuana’s abuse potential and level of physical or psychological dependence. The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-06-24T20:02:18Z", "dkAbstract": "The Department of Justice is proposing to transfer clinical marijuana from schedule I of the Controlled Substances Act (\u201cCSA\u201d) to schedule III of the CSA, consistent with the view of the Department of Health and Human Services (\u201cHHS\u201d) that marijuana has a currently accepted medical use as well as HHS\u2019s views about marijuana\u2019s abuse potential and level of physical or psychological dependence. The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Rescheduling of Marijuana", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648656cd99"} | single_get | |||||||
| DEA-2025-0885 | DEA | Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420) | Rulemaking | 2026-06-24T19:58:54Z | 0b000064b90d3674 | Not Assigned | The Drug Enforcement Administration proposes to schedule 8-bromo-1-methyl-6- phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-06-24T19:58:54Z", "dkAbstract": "The Drug Enforcement Administration proposes to schedule 8-bromo-1-methyl-6-\nphenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b90d3674"} | single_get | |||||||
| DEA-2020-0031 | DEA | Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment | Rulemaking | 2026-06-24T19:56:20Z | 0b00006484946331 | 1117-AB55 | The ‘‘Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (the SUPPORT Act),’’ expand the conditions a practitioner must meet to provide medication-assisted treatment for opioid use disorder and expand the options available for a physician to be considered a qualifying physician. The SUPPORT Act also allowed a pharmacy to a practitioner’s registered location for the purpose of maintenance or detoxification treatment to be administered under certain conditions. On December 29, 2022, the Restoring Hope for Mental Health and Well-Being Act of 2022 removed many of the statutory provisions of the SUPPORT Act. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-06-24T19:56:20Z", "dkAbstract": "The \u2018\u2018Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (the SUPPORT Act),\u2019\u2019 expand the conditions a practitioner must meet to provide medication-assisted treatment for opioid use disorder and expand the options available for a physician to be considered a qualifying physician. The SUPPORT Act also allowed a pharmacy to a practitioner\u2019s registered location for the purpose of maintenance or detoxification treatment to be administered under certain conditions. On December 29, 2022, the Restoring Hope for Mental Health and Well-Being Act of 2022 removed many of the statutory provisions of the SUPPORT Act.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB55", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484946331"} | single_get | |||||||
| DEA-2026-0893 | DEA | Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products (DEA1664) | Rulemaking | 2026-06-16T16:24:31Z | 0b000064b92f149e | Not Assigned | The Drug Enforcement Administration (DEA) proposes to revoke the exempted status for certain nonnarcotic prescription products that are currently on DEA’s Table of Exempted Prescription Products list but whose National Drug Code (NDC) is inactive because they are no longer available and/or the company that applied for the exemption no longer exists. If finalized, these products would be removed from DEA’s Table of Exempted Prescription Products list, and they would no longer be considered exempt prescription products under the Controlled Substances Act. This action will not impact exempted prescription products with active NDC numbers | {"displayProperties": [], "keywords": null, "modifyDate": "2026-06-16T16:24:31Z", "dkAbstract": "The Drug Enforcement Administration (DEA) proposes to revoke the exempted status for certain nonnarcotic prescription products that are currently on DEA\u2019s Table of Exempted Prescription Products list but whose National Drug Code (NDC) is inactive because they are no longer available and/or the company that applied for the exemption no longer exists. If finalized, these products would be removed from DEA\u2019s Table of Exempted Prescription Products list, and they would no longer be considered exempt prescription products under the Controlled Substances Act. This action will not impact exempted prescription products with active NDC numbers", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products (DEA1664)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b92f149e"} | single_get | |||||||
| DEA-2026-0793 | DEA | Revision of Applications for Manufacturing and Procurement Quotas | Rulemaking | 2026-06-15T13:46:57Z | 0b000064b92e50d2 | 1117-AB86 | The Drug Enforcement Administration (DEA) proposes to revise existing regulations relating to the management of quotas for schedule I and II controlled substances and the list I chemicals, ephedrine, pseudoephedrine, and phenylpropanolamine, to be utilized by DEA-registered manufacturers. This rule is being proposed to: restructure DEA's manufacturing and procurement quota regulations for more clarity and consistency; clarify which use-specific subcategories for quotas should be used for controlled substances that will be sold domestically and controlled substances that will be exported; and revise the applications for individual manufacturing and procurement quota. The changes are necessary to increase visibility into the controlled substance supply chain by providing DEA with more detailed information allowing the agency to react more precisely in preventing drug shortages; and to ensure that enough of the schedule I and II controlled substances and three list I chemicals can be manufactured to meet estimated scientific, medical, lawful export, and inventory needs. This rule also contains revisions to use gender neutral language and other non-substantive revisions. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-06-15T13:46:57Z", "dkAbstract": "The Drug Enforcement Administration (DEA) proposes to revise existing regulations relating to the management of quotas for schedule I and II controlled substances and the list I chemicals, ephedrine, pseudoephedrine, and phenylpropanolamine, to be utilized by DEA-registered manufacturers. This rule is being proposed to: restructure DEA's manufacturing and procurement quota regulations for more clarity and consistency; clarify which use-specific subcategories for quotas should be used for controlled substances that will be sold domestically and controlled substances that will be exported; and revise the applications for individual manufacturing and procurement quota. The changes are necessary to increase visibility into the controlled substance supply chain by providing DEA with more detailed information allowing the agency to react more precisely in preventing drug shortages; and to ensure that enough of the schedule I and II controlled substances and three list I chemicals can be manufactured to meet estimated scientific, medical, lawful export, and inventory needs. This rule also contains revisions to use gender neutral language and other non-substantive revisions.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Revision of Applications for Manufacturing and Procurement Quotas", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB86", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b92e50d2"} | single_get | |||||||
| DEA-2026-0133 | DEA | Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442) | Rulemaking | 2026-05-26T18:00:02Z | 0b000064b9161bed | Not Assigned | The Drug Enforcement Administration (DEA) issues this temporary order to schedule 2-(2- fluorophenyl)-2- (methylamino)cyclohexan-1-one (commonly known as 2- fluorodeschloroketamine or 2–FDCK), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing 2- fluorodeschloroketamine in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle or propose to handle this substance. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-05-26T18:00:02Z", "dkAbstract": "The Drug Enforcement Administration (DEA) issues this temporary order to schedule 2-(2- fluorophenyl)-2- (methylamino)cyclohexan-1-one (commonly known as 2- fluorodeschloroketamine or 2\u2013FDCK), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing 2- fluorodeschloroketamine in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle or propose to handle this substance.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b9161bed"} | single_get | |||||||
| DEA-2025-0918 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) | Rulemaking | 2026-05-13T19:43:01Z | 0b000064b90dd26c | Not Assigned | Drug Enforcement Administration is extending the temporary schedule I status of 4F-MDMB-BUTICA, ADB-4enPINACA, 5F-EDMB-PICA, and MMBFUBICA. This temporary order will extend the temporary scheduling of these four substances for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will continue to be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle this drug. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-05-13T19:43:01Z", "dkAbstract": "Drug Enforcement Administration is extending the temporary schedule I status of 4F-MDMB-BUTICA, ADB-4enPINACA, 5F-EDMB-PICA, and MMBFUBICA. This temporary order will extend the temporary scheduling of these four substances for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will continue to be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle this drug.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b90dd26c"} | single_get | |||||||
| DEA-2025-0852 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) | Rulemaking | 2026-05-13T19:38:06Z | 0b000064b90c539c | Not Assigned | The Drug Enforcement Administration proposes placing the substance CUMYL-PEGACLONE (SGT151; 5-pentyl-2-(2-phenylpropan-2- yl)pyrido[4,3-b]indol-1-one), including its salts, isomers (including optical, positional, and geometric isomers), and salts of isomers, in schedule I of the Controlled Substances Act. CUMYLPEGACLONE was temporarily scheduled in an order dated December 12, 2023. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-05-13T19:38:06Z", "dkAbstract": "The Drug Enforcement Administration proposes placing the substance CUMYL-PEGACLONE (SGT151; 5-pentyl-2-(2-phenylpropan-2- yl)pyrido[4,3-b]indol-1-one), including its salts, isomers (including optical, positional, and geometric isomers), and salts of isomers, in schedule I of the Controlled Substances Act. CUMYLPEGACLONE was temporarily scheduled in an order dated December 12, 2023. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b90c539c"} | single_get | |||||||
| DEA-2025-0557 | DEA | Designation of P2P Methyl Glycidic Acid as a List I Chemical (DEA1395) | Rulemaking | 2026-05-13T19:37:38Z | 0b000064b8fefe8d | Not Assigned | The Drug Enforcement Administration is proposing the control of the chemical 2-methyl-3- phenyloxirane-2-carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible, as a list I chemical under the Controlled Substances Act (CSA). P2P methyl glycidic acid is important to the manufacture of the schedule II controlled substances phenylacetone (also known as phenyl-2-propanone or P2P), methamphetamine, and amphetamine, and it is used in clandestine laboratories to illicitly manufacture these controlled substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-05-13T19:37:38Z", "dkAbstract": "The Drug Enforcement Administration is proposing the control of the chemical 2-methyl-3- phenyloxirane-2-carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible, as a list I chemical under the Controlled Substances Act (CSA). P2P methyl glycidic acid is important to the manufacture of the schedule II controlled substances phenylacetone (also known as phenyl-2-propanone or P2P), methamphetamine, and amphetamine, and it is used in clandestine laboratories to illicitly manufacture these controlled substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Designation of P2P Methyl Glycidic Acid as a List I Chemical (DEA1395)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b8fefe8d"} | single_get | |||||||
| DEA-2025-0555 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) | Rulemaking | 2026-05-13T19:37:16Z | 0b000064b8fefe20 | Not Assigned | The Drug Enforcement Administration proposes placing methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1Hindazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-05-13T19:37:16Z", "dkAbstract": "The Drug Enforcement Administration proposes placing methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1Hindazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b8fefe20"} | single_get | |||||||
| DEA-2026-0727 | DEA | Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA1632) | Rulemaking | 2026-05-13T19:35:24Z | 0b000064b92d5942 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2026-05-13T19:35:24Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA1632)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b92d5942"} | single_get | ||||||||
| DEA-2025-0654 | DEA | Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026 | Rulemaking | 2026-04-20T16:02:07Z | 0b000064b909f13a | Not Assigned | To allow the Drug Enforcement Administration (DEA) to establish the 2026 aggregate production quota (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. These values need to be publicly established before allocating individual quotas to manufacturers necessary to provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-04-20T16:02:07Z", "dkAbstract": "To allow the Drug Enforcement Administration (DEA) to establish the 2026 aggregate production quota (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. These values need to be publicly established before allocating individual quotas to manufacturers necessary to provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b909f13a"} | single_get | |||||||
| DEA-2025-0081 | DEA | Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl] piperidine) in Schedule I (DEA1146) | Rulemaking | 2026-04-03T17:51:43Z | 0b000064b8ddd142 | Not Assigned | The Drug Enforcement Administration proposes placing 3-methoxyphencyclidine, as identified in this proposed rule, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substance. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle 3-methoxyphencyclidine. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-04-03T17:51:43Z", "dkAbstract": "The Drug Enforcement Administration proposes placing 3-methoxyphencyclidine, as identified in this proposed rule, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substance. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle 3-methoxyphencyclidine.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl] piperidine) in Schedule I (DEA1146)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b8ddd142"} | single_get | |||||||
| DEA-2023-0138 | DEA | Designation of Propionyl Chloride as a List I Chemical (DEA1189) | Rulemaking | 2026-04-03T17:48:25Z | 0b000064860bbba7 | Not Assigned | The Drug Enforcement Administration is proposing the control of propionyl chloride as a list I chemical under the Controlled Substances Act. The DEA finds that propionyl chloride is used in the illicit manufacture of the controlled substances fentanyl, fentanyl analogues, and fentanyl-related substances, and is important to the manufacture of these substances. In the respective synthetic pathways in which it is used to manufacture those substances, it is a replacement for propionic anhydride, which is currently a list I chemical. The proposed rule would subject handlers of propionyl chloride to the chemical regulatory provisions of the CSA and its implementing regulations. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-04-03T17:48:25Z", "dkAbstract": "The Drug Enforcement Administration is proposing the control of propionyl chloride as a list I chemical under the Controlled Substances Act. The DEA finds that propionyl chloride is used in the illicit manufacture of the controlled substances fentanyl, fentanyl analogues, and fentanyl-related substances, and is important to the manufacture of these substances. In the respective synthetic pathways in which it is used to manufacture those substances, it is a replacement for propionic anhydride, which is currently a list I chemical. The proposed rule would subject handlers of propionyl chloride to the chemical regulatory provisions of the CSA and its implementing regulations.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Designation of Propionyl Chloride as a List I Chemical (DEA1189)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064860bbba7"} | single_get | |||||||
| DEA-2022-0145 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) | Rulemaking | 2026-04-03T17:47:33Z | 0b0000648554cfe6 | Not Assigned | NPRM | {"displayProperties": [], "keywords": null, "modifyDate": "2026-04-03T17:47:33Z", "dkAbstract": "NPRM", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648554cfe6"} | single_get | |||||||
| DEA-2020-0029 | DEA | Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017 | Rulemaking | 2026-04-03T17:44:35Z | 0b000064848b8dbc | 1117-AB37 | Regulations that implement the Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017 | {"displayProperties": [], "keywords": null, "modifyDate": "2026-04-03T17:44:35Z", "dkAbstract": "Regulations that implement the Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB37", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064848b8dbc"} | single_get | |||||||
| DEA-2026-0595 | DEA | Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments (DEA1005) | Rulemaking | 2026-04-03T17:43:47Z | 0b000064b924e5b5 | Not Assigned | DEA is correcting regulations regarding the execution of a POA for DEA Form 222. The corrected regulations will resolve conflicting language by conforming all details of the rule to the intent of the current regulation which requires that a POA to order controlled substances to be signed by an officer of a corporation, corporate division, association, trust or other entity. This action makes no substantive changes to the regulations. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-04-03T17:43:47Z", "dkAbstract": "DEA is correcting regulations regarding the execution of a POA for DEA Form 222. The corrected regulations will resolve conflicting language by conforming all details of the rule to the intent of the current regulation which requires that a POA to order controlled substances to be signed by an officer of a corporation, corporate division, association, trust or other entity. This action makes no substantive changes to the regulations.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments (DEA1005)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b924e5b5"} | single_get | |||||||
| DEA-2023-0057 | DEA | Definition of ‘‘Cannabimimetic Agents’’ and Assignment of an Administration Controlled Substances Code Number for All ‘‘Cannabimimetic Agents’’ (DEA368) | Rulemaking | 2026-01-20T18:44:45Z | 0b00006485945c83 | Not Assigned | On July 9, 2012, the President signed into law the Synthetic Drug Abuse Prevention Act of 2012. The Synthetic Drug Abuse Prevention Act of 2012 included a definition of “cannabimimetic agents” that are controlled under Schedule I. The Drug Enforcement Administration is publishing this rule to establish drug codes for additional substances that meet the structural and pharmacological definition of “cannabimimetic agents” in accordance with the Synthetic Drug Abuse Prevention Act of 2012. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-01-20T18:44:45Z", "dkAbstract": "On July 9, 2012, the President signed into law the Synthetic Drug Abuse Prevention Act of 2012.\u00a0 The Synthetic Drug Abuse Prevention Act of 2012 included a definition of \u201ccannabimimetic agents\u201d that are controlled under Schedule I.\u00a0 The Drug Enforcement Administration is publishing this rule to establish drug codes for additional substances that meet the structural and pharmacological definition of \u201ccannabimimetic agents\u201d in accordance with the Synthetic Drug Abuse Prevention Act of 2012.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Definition of \u2018\u2018Cannabimimetic Agents\u2019\u2019 and Assignment of an Administration Controlled Substances Code Number for All \u2018\u2018Cannabimimetic Agents\u2019\u2019 (DEA368)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485945c83"} | single_get | |||||||
| DEA-2025-0075 | DEA | Placement of 4-Fluoroamphetamine in Schedule I (DEA1180) | Rulemaking | 2026-01-16T15:16:59Z | 0b000064b8dc49a1 | Not Assigned | The Drug Enforcement Administration proposes placing 4-fluoroamphetamine, as identified in this proposed rule, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substance. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle 4-fluoroamphetamine. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-01-16T15:16:59Z", "dkAbstract": "The Drug Enforcement Administration proposes placing 4-fluoroamphetamine, as identified in this proposed rule, in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substance. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle 4-fluoroamphetamine.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of 4-Fluoroamphetamine in Schedule I (DEA1180)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b8dc49a1"} | single_get | |||||||
| DEA-2023-0029 | DEA | Telemedicine Prescribing of Controlled Substances (DEA407) | Rulemaking | 2026-01-12T22:00:12Z | 0b00006485728671 | 1117-AB40 | The Drug Enforcement Administration proposes a Special Registration for Telemedicine framework, authorizing certain DEA-registered practitioners to engage in the practice of telemedicine under the Ryan Haight Act. The three types of Special Registration, include: (1) the Telemedicine Prescribing Registration, authorizing qualified clinician practitioners to prescribe Schedule III-V controlled substances; (2) the Advanced Telemedicine Prescribing Registration, authorizing qualified specialized clinician practitioners to prescribe Schedule II-V controlled substances; and (3) the Telemedicine Platform Registration authorizing qualified covered online telemedicine platforms, in their capacity as platform practitioners, to dispense Schedule II-V controlled substances. The rule also provides heightened prescription, recordkeeping, and reporting requirements. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-01-12T22:00:12Z", "dkAbstract": "The Drug Enforcement Administration proposes a Special Registration for Telemedicine framework, authorizing certain DEA-registered practitioners to engage in the practice of telemedicine under the Ryan Haight Act. The three types of Special Registration, include: (1) the Telemedicine Prescribing Registration, authorizing qualified clinician practitioners to prescribe Schedule III-V controlled substances; (2) the Advanced Telemedicine Prescribing Registration, authorizing qualified specialized clinician practitioners to prescribe Schedule II-V controlled substances; and (3) the Telemedicine Platform Registration authorizing qualified covered online telemedicine platforms, in their capacity as platform practitioners, to dispense Schedule II-V controlled substances. The rule also provides heightened prescription, recordkeeping, and reporting requirements.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Telemedicine Prescribing of Controlled Substances (DEA407)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB40", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485728671"} | single_get | |||||||
| DEA-2024-0118 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337) | Rulemaking | 2026-01-12T21:58:59Z | 0b00006486732eab | Not Assigned | The Drug Enforcement Administration intends to temporarily schedule two synthetic benzimidazole-opioid substances, N-pyrrolidino metonitazene and N-pyrrolidino protonitazene, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (whenever the existence of such is possible), in schedule I of the Controlled Substances Act. Once issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these two specified substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-01-12T21:58:59Z", "dkAbstract": "The Drug Enforcement Administration intends to temporarily schedule two synthetic benzimidazole-opioid substances, N-pyrrolidino metonitazene and N-pyrrolidino protonitazene, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (whenever the existence of such is possible), in schedule I of the Controlled Substances Act. Once issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these two specified substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486732eab"} | single_get | |||||||
| DEA-2023-0147 | DEA | Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143) | Rulemaking | 2026-01-05T20:10:17Z | 0b0000648613cdb2 | Not Assigned | This temporary order will schedule two synthetic benzimidazole-opioid substances, as identified in the order, in schedule I of the Controlled Substances Act. This action is based on a finding by the Administrator that placement of these two substances in schedule I is necessary to avoid imminent hazard to the public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these two specified controlled substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2026-01-05T20:10:17Z", "dkAbstract": "This temporary order will schedule two synthetic benzimidazole-opioid substances, as identified in the order, in schedule I of the Controlled Substances Act. This action is based on a finding by the Administrator that placement of these two substances in schedule I is necessary to avoid imminent hazard to the public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these two specified controlled substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648613cdb2"} | single_get | |||||||
| DEA-2024-0144 | DEA | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) | Rulemaking | 2025-11-19T21:13:12Z | 0b00006486891ffe | Not Assigned | The Drug Enforcement Administration proposes placing the substance 4- chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 4-chloromethcathinone. | {"displayProperties": [], "keywords": null, "modifyDate": "2025-11-19T21:13:12Z", "dkAbstract": "The Drug Enforcement Administration proposes placing the substance 4- chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 4-chloromethcathinone.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486891ffe"} | single_get | |||||||
| DEA-2025-0588 | DEA | Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494) | Rulemaking | 2025-10-16T23:33:17Z | 0b000064b9030281 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2025-10-16T23:33:17Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b9030281"} | single_get | ||||||||
| DEA-2025-0192 | DEA | Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (DEA1390) | Rulemaking | 2025-10-16T23:28:47Z | 0b000064b8ec6630 | Not Assigned | Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance - final rule | {"displayProperties": [], "keywords": null, "modifyDate": "2025-10-16T23:28:47Z", "dkAbstract": "Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance - final rule", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (DEA1390)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b8ec6630"} | single_get | |||||||
| DEA-2023-0016 | DEA | Controlled Substances Ordering System Modernization (DEA732) | Rulemaking | 2025-10-02T21:31:46Z | 0b0000648562ccb3 | 1117-AB79 | DEA is amending its regulations to transfer all paper applications for Certification for Controlled Substance Ordering System to online applications. Moreover, DEA is removing the requirement for the application to be notarized | {"displayProperties": [], "keywords": null, "modifyDate": "2025-10-02T21:31:46Z", "dkAbstract": "DEA is amending its regulations to transfer all paper applications for Certification for Controlled Substance Ordering System to online applications. Moreover, DEA is removing the requirement for the application to be notarized", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Controlled Substances Ordering System Modernization (DEA732)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB79", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648562ccb3"} | single_get | |||||||
| DEA-2025-0558 | DEA | Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction (DEA1111) | Rulemaking | 2025-10-02T21:30:04Z | 0b000064b8fefe93 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2025-10-02T21:30:04Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction (DEA1111)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b8fefe93"} | single_get | ||||||||
| DEA-2024-0148 | DEA | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) | Rulemaking | 2025-10-02T21:28:47Z | 0b00006486894bb0 | Not Assigned | The Drug Enforcement Administration proposes placing seven fentanyl-related substances in schedule I of the Controlled Substances Act. These seven substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018 temporary scheduling order. This temporary order was subsequently extended multiple times, most recently through the Consolidated Appropriations Act, 2023, which extended the order until December 31, 2024. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle or propose to handle these seven specific controlled substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2025-10-02T21:28:47Z", "dkAbstract": "The Drug Enforcement Administration proposes placing seven fentanyl-related substances in schedule I of the Controlled Substances Act. These seven substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018 temporary scheduling order. This temporary order was subsequently extended multiple times, most recently through the Consolidated Appropriations Act, 2023, which extended the order until December 31, 2024. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle or propose to handle these seven specific controlled substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486894bb0"} | single_get | |||||||
| DEA-2025-0556 | DEA | Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical | Rulemaking | 2025-10-02T21:22:21Z | 0b000064b8fefe24 | Not Assigned | The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Chemical Code Number for tert-butyl 4-oxopiperidine1-carboxylate (also known as 1-boc-4- piperidone; and CAS Number: 79099– 07–3) and its salts as a list I chemical under the Controlled Substances Act (CSA). Although 1-boc-4-piperidone is not specifically listed as a list I chemical of the CSA with its own unique Chemical Code Number, it has been regulated as a list I chemical in the United States as a carbamate of 4- piperidone, a list I chemical, since May 12, 2023. | {"displayProperties": [], "keywords": null, "modifyDate": "2025-10-02T21:22:21Z", "dkAbstract": "The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Chemical Code Number for tert-butyl 4-oxopiperidine1-carboxylate (also known as 1-boc-4- piperidone; and CAS Number: 79099\u2013 07\u20133) and its salts as a list I chemical under the Controlled Substances Act (CSA). Although 1-boc-4-piperidone is not specifically listed as a list I chemical of the CSA with its own unique Chemical Code Number, it has been regulated as a list I chemical in the United States as a carbamate of 4- piperidone, a list I chemical, since May 12, 2023.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b8fefe24"} | single_get | |||||||
| DEA-2024-0120 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025 | Rulemaking | 2025-09-19T16:15:52Z | 0b00006486783c5d | Not Assigned | The Drug Enforcement Administration (DEA) proposes to establish the 2025 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. DEA-1413P | {"displayProperties": [], "keywords": null, "modifyDate": "2025-09-19T16:15:52Z", "dkAbstract": "The Drug Enforcement \nAdministration (DEA) proposes to \nestablish the 2025 aggregate production \nquotas for controlled substances in \nschedules I and II of the Controlled \nSubstances Act (CSA) and the \nassessment of annual needs for the list \nI chemicals ephedrine, \npseudoephedrine, and \nphenylpropanolamine. \nDEA-1413P", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486783c5d"} | single_get | |||||||
| DEA-2024-0026 | DEA | Placement of 2-Methyl AP-237 in Schedule I (DEA1245) | Rulemaking | 2025-07-28T18:22:10Z | 0b00006486484632 | Not Assigned | The Drug Enforcement Administration is permanently placing 1-(2-methyl-4-(3- phenylprop-2-en-1-yl)piperazin-1- yl)butan-1-one (commonly known as 2- methyl AP–237), including its optical and geometric isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle 2-methyl AP–237. | {"displayProperties": [], "keywords": null, "modifyDate": "2025-07-28T18:22:10Z", "dkAbstract": "The Drug Enforcement Administration is permanently placing 1-(2-methyl-4-(3- phenylprop-2-en-1-yl)piperazin-1- yl)butan-1-one (commonly known as 2- methyl AP\u2013237), including its optical and geometric isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle 2-methyl AP\u2013237.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of 2-Methyl AP-237 in Schedule I (DEA1245)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486484632"} | single_get | |||||||
| DEA-2023-0148 | DEA | Destruction Alternatives to Incineration (DEA1144) | Rulemaking | 2025-07-28T18:21:23Z | 0b0000648618d50c | 1117-AB84 | {"displayProperties": [], "keywords": null, "modifyDate": "2025-07-28T18:21:23Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Destruction Alternatives to Incineration (DEA1144)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB84", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648618d50c"} | single_get | ||||||||
| DEA-2025-0078 | DEA | Three specific fentanyl-related substances (para-bromofentanyl, para-fluoroacetyl fentanyl, and para-methyl acetyl fentanyl) (DEA1484) | Rulemaking | 2025-07-28T18:18:20Z | 0b000064b8dd586c | Not Assigned | The Drug Enforcement Administration proposes to permanently schedule three fentanyl-related substances, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These three substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018 temporary scheduling order. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle these three specific controlled substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2025-07-28T18:18:20Z", "dkAbstract": "The Drug Enforcement Administration proposes to permanently schedule three fentanyl-related substances, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These three substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018 temporary scheduling order. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle these three specific controlled substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Three specific fentanyl-related substances (para-bromofentanyl, para-fluoroacetyl fentanyl, and para-methyl acetyl fentanyl) (DEA1484)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064b8dd586c"} | single_get | |||||||
| DEA-2023-0098 | DEA | Implementation of the Designer Anabolic Steroid Control Act of 2014 (DEA481) | Rulemaking | 2025-07-07T16:45:39Z | 0b00006485d9c470 | 1117-AB81 | {"displayProperties": [], "keywords": null, "modifyDate": "2025-07-07T16:45:39Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Implementation of the Designer Anabolic Steroid Control Act of 2014 (DEA481)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB81", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485d9c470"} | single_get | ||||||||
| DEA-2021-0003 | DEA | Suspicious Orders of Controlled Substances | Rulemaking | 2025-06-05T16:32:03Z | 0b000064849e1a2e | 1117-AB47 | {"displayProperties": [], "keywords": null, "modifyDate": "2025-06-05T16:32:03Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Suspicious Orders of Controlled Substances", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB47", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064849e1a2e"} | single_get | ||||||||
| DEA-2023-0028 | DEA | Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948) | Rulemaking | 2025-06-02T20:11:54Z | 0b0000648572859f | 1117-AB78 | The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) are expanding the circumstances under which practitioners registered by the DEA are authorized to prescribe schedule III-V controlled substances approved for the treatment of opioid use disorder via a telemedicine encounter, including an audio-only encounter. Under these regulations, practitioners may prescribe up to an initial six-month supply through audio-only means. Practitioners must review the patient’s prescription drug monitoring program for the state in which the patient is located prior to prescribing. Pharmacists are required to verify the identity of the patient prior to filling a prescription. | {"displayProperties": [], "keywords": null, "modifyDate": "2025-06-02T20:11:54Z", "dkAbstract": "The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) are expanding the circumstances under which practitioners registered by the DEA are authorized to prescribe schedule III-V controlled substances approved for the treatment of opioid use disorder via a telemedicine encounter, including an audio-only encounter. Under these regulations, practitioners may prescribe up to an initial six-month supply through audio-only means. Practitioners must review the patient\u2019s prescription drug monitoring program for the state in which the patient is located prior to prescribing. Pharmacists are required to verify the identity of the patient prior to filling a prescription.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB78", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648572859f"} | single_get | |||||||
| DEA-2023-0168 | DEA | Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156) | Rulemaking | 2025-02-21T15:50:53Z | 0b00006486330ce3 | Not Assigned | The Drug Enforcement Administration proposes placing two phenethylamine hallucinogens in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances for one of these substances 2,5-dimethoxy-4-chloroamphetamine. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle these two specific controlled substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2025-02-21T15:50:53Z", "dkAbstract": "The Drug Enforcement Administration proposes placing two phenethylamine hallucinogens in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances for one of these substances 2,5-dimethoxy-4-chloroamphetamine. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle these two specific controlled substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486330ce3"} | single_get | |||||||
| DEA-2023-0150 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024 (DEA1228) | Rulemaking | 2025-02-21T15:50:43Z | 0b000064861df091 | Not Assigned | The Drug Enforcement Administration proposes to adjust the 2024 aggregate production quotas for several controlled substances in schedules I and II of the Controlled Substances Act. Additionally, as DEA announced in an April 29, 2024 letter to DEA-registered manufacturers, procurement quotas for commercial manufacturing of a schedule II controlled substance will be calculated on a semi-annual basis, except for injectable drug products containing schedule II controlled substances, which will be calculated on an annual basis. | ["DEA-1228A"] | {"displayProperties": [], "keywords": ["DEA-1228A"], "modifyDate": "2025-02-21T15:50:43Z", "dkAbstract": "The Drug Enforcement Administration proposes to adjust the 2024 aggregate production quotas for several controlled substances in schedules I and II of the Controlled Substances Act. Additionally, as DEA announced in an April 29, 2024 letter to DEA-registered manufacturers, procurement quotas for commercial manufacturing of a schedule II controlled substance will be calculated on a semi-annual basis, except for injectable drug products containing schedule II controlled substances, which will be calculated on an annual basis.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024 (DEA1228)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064861df091"} | single_get | ||||||
| DEA-2024-0134 | DEA | Control of Phenethyl Bromide as a List I Chemical (DEA1282) | Rulemaking | 2025-01-07T09:13:06Z | 0b0000648683d06e | Not Assigned | The Drug Enforcement Administration (DEA) finds that phenethyl bromide is used in the illicit manufacture of the controlled substance fentanyl, as well as fentanyl analogues and fentanyl-related substances, and is important to the manufacture of these substances because it is often used in synthetic pathways to illicitly manufacture fentanyl, fentanyl analogues, and fentanyl-related substances. Prior to proposing to list phenethyl bromide as a list I chemical under the Controlled Substances Act, DEA is soliciting information on its current uses (other than for the synthesis of fentanyl) to properly determine the effect a proposed action would have on legitimate industry. | {"displayProperties": [], "keywords": null, "modifyDate": "2025-01-07T09:13:06Z", "dkAbstract": "The Drug Enforcement Administration (DEA) finds that phenethyl bromide is used in the illicit manufacture of the controlled substance fentanyl, as well as fentanyl analogues and fentanyl-related substances, and is important to the manufacture of these substances because it is often used in synthetic pathways to illicitly manufacture fentanyl, fentanyl analogues, and fentanyl-related substances. Prior to proposing to list phenethyl bromide as a list I chemical under the Controlled Substances Act, DEA is soliciting information on its current uses (other than for the synthesis of fentanyl) to properly determine the effect a proposed action would have on legitimate industry. ", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Control of Phenethyl Bromide as a List I Chemical (DEA1282)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648683d06e"} | single_get | |||||||
| DEA-2021-0031 | DEA | Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I | Rulemaking | 2024-10-25T14:56:30Z | 0b00006484ea7ed9 | Not Assigned | This rule addresses the scheduling and temporary scheduling of 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene; etazene), 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (N-pyrrolidino etonitazene; etonitazepyne), and N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever such isomers, esters, ethers, and salts are possible within the specific chemical designation. This scheduling action discharges the United States’ obligations under the Single Convention on Narcotic Drugs (1961) and imposes permanent regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess these substances. | {"displayProperties": [], "keywords": null, "modifyDate": "2024-10-25T14:56:30Z", "dkAbstract": "This rule addresses the scheduling and temporary scheduling of 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene; etazene), 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (N-pyrrolidino etonitazene; etonitazepyne), and N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever such isomers, esters, ethers, and salts are possible within the specific chemical designation. This scheduling action discharges the United States\u2019 obligations under the Single Convention on Narcotic Drugs (1961) and imposes permanent regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess these substances.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484ea7ed9"} | single_get | |||||||
| DEA-2023-0129 | DEA | Placement of Ethylphenidate in Schedule I (DEA1142) | Rulemaking | 2024-10-24T10:27:34Z | 0b00006485fe80fd | Not Assigned | The Drug Enforcement Administration is placing ethylphenidate (chemical name: ethyl 2-phenyl-2- (piperidin-2-yl)acetate), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle ethylphenidate. | {"displayProperties": [], "keywords": null, "modifyDate": "2024-10-24T10:27:34Z", "dkAbstract": "The Drug Enforcement Administration is placing ethylphenidate (chemical name: ethyl 2-phenyl-2- (piperidin-2-yl)acetate), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle ethylphenidate.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of Ethylphenidate in Schedule I (DEA1142)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485fe80fd"} | single_get | |||||||
| DEA-2023-0149 | DEA | Placement of Zuranolone in Schedule IV (DEA1258) | Rulemaking | 2024-09-03T18:47:04Z | 0b000064861a0975 | Not Assigned | This rule places zuranolone (chemically known as 1-[2- [(3R,5R,8R,9R,10S,13S,14S,17S)-3- hydroxy-3,13-dimethyl2,4,5,6,7,8,9,10,11,12,14,15,16,17- tetradecahydro-1Hcyclopenta[a]phenanthren-17-yl]-2- oxoethyl]pyrazole-4-carbonitrile) and its salts in schedule IV of the Controlled Substances Act. | {"displayProperties": [], "keywords": null, "modifyDate": "2024-09-03T18:47:04Z", "dkAbstract": "This rule places zuranolone (chemically known as 1-[2- [(3R,5R,8R,9R,10S,13S,14S,17S)-3- hydroxy-3,13-dimethyl2,4,5,6,7,8,9,10,11,12,14,15,16,17- tetradecahydro-1Hcyclopenta[a]phenanthren-17-yl]-2- oxoethyl]pyrazole-4-carbonitrile) and its salts in schedule IV of the Controlled Substances Act. ", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of Zuranolone in Schedule IV (DEA1258)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064861a0975"} | single_get | |||||||
| DEA-2022-0058 | DEA | Providing CS to Ocean Vessels, Aircraft, and Other Entities | Rulemaking | 2024-08-26T13:13:33Z | 0b0000648514e942 | 1117-AB60 | DEA is proposing to revise the regulations regarding controlled substances acquired by a medical officer to be maintained in, and dispensed from medicine chests, first aid packets, or dispensaries on board vessels, aircraft, and other entities. DEA is proposing to create a new “medical officer” registration category under the dispensing business activity and require a practitioner who serves or wishes to serve as a medical officer to be registered specifically as a “medical officer.” Other revisions being proposed would, among other things, clarify the types of entities allowed to acquire controlled substances, clarify the registration status of such entities, and deem the personal use of controlled substances during an emergency on board a vessel or aircraft owned and legally operated by a registered individual practitioner as a coincident activity under the practitioner’s existing registration. | {"displayProperties": [], "keywords": null, "modifyDate": "2024-08-26T13:13:33Z", "dkAbstract": "DEA is proposing to revise the regulations regarding controlled substances acquired by a medical officer to be maintained in, and dispensed from medicine chests, first aid packets, or dispensaries on board vessels, aircraft, and other entities. DEA is proposing to create a new \u201cmedical officer\u201d registration category under the dispensing business activity and require a practitioner who serves or wishes to serve as a medical officer to be registered specifically as a \u201cmedical officer.\u201d Other revisions being proposed would, among other things, clarify the types of entities allowed to acquire controlled substances, clarify the registration status of such entities, and deem the personal use of controlled substances during an emergency on board a vessel or aircraft owned and legally operated by a registered individual practitioner as a coincident activity under the practitioner\u2019s existing registration.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Providing CS to Ocean Vessels, Aircraft, and Other Entities", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB60", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648514e942"} | single_get | |||||||
| DEA-2024-0009 | DEA | Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014 | Rulemaking | 2024-08-26T13:13:33Z | 0b000064863e8464 | 1117-AB82 | The Drug Enforcement Administration is amending its regulations to codify the VMMA. This rule merely conforms DEA regulations to statutory amendments of the Controlled Substances Act that have already taken effect and makes no substantive change to existing legal requirements. | {"displayProperties": [], "keywords": null, "modifyDate": "2024-08-26T13:13:33Z", "dkAbstract": "The Drug Enforcement Administration is amending its regulations to codify the VMMA. This rule merely conforms DEA regulations to statutory amendments of the Controlled Substances Act that have already taken effect and makes no substantive change to existing legal requirements.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB82", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064863e8464"} | single_get | |||||||
| DEA-2021-0027 | DEA | Regulation of Telepharmacy Practice | Rulemaking | 2024-08-26T13:06:55Z | 0b00006484e57207 | 1117-AB74 | {"displayProperties": [], "keywords": null, "modifyDate": "2024-08-26T13:06:55Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Regulation of Telepharmacy Practice", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB74", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484e57207"} | single_get | ||||||||
| DEA-2020-0023 | DEA | Implementation of the Agricultural Improvement Act | Rulemaking | 2024-08-26T13:03:33Z | 0b0000648481bb3b | 1117-AB53 | {"displayProperties": [], "keywords": null, "modifyDate": "2024-08-26T13:03:33Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Implementation of the Agricultural Improvement Act", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB53", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648481bb3b"} | single_get | ||||||||
| DEA-2010-0010 | DEA | Electronic Prescriptions for Controlled Substances | Rulemaking | 2024-08-26T13:00:45Z | 0b00006480acce59 | 1117-AA61 | {"displayProperties": [], "keywords": null, "modifyDate": "2024-08-26T13:00:45Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Electronic Prescriptions for Controlled Substances", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AA61", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006480acce59"} | single_get | ||||||||
| DEA-2021-0005 | DEA | Amending Regulations to Require Online Submission of Applications for and Renewals of DEA Registration | Rulemaking | 2024-07-12T12:24:57Z | 0b000064849e58a9 | 1117-AB58 | {"displayProperties": [], "keywords": null, "modifyDate": "2024-07-12T12:24:57Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Amending Regulations to Require Online Submission of Applications for and Renewals of DEA Registration", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB58", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064849e58a9"} | single_get | ||||||||
| DEA-2021-0009 | DEA | MAPA - Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine | Rulemaking | 2024-06-11T01:13:26Z | 0b00006484aeb507 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2024-06-11T01:13:26Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "MAPA - Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484aeb507"} | single_get | ||||||||
| DEA-2022-0120 | DEA | Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023 | Rulemaking | 2024-02-12T10:32:02Z | 0b000064854169b8 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2024-02-12T10:32:02Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064854169b8"} | single_get | ||||||||
| DEA-2023-0169 | DEA | Specific Listing for Three Currently Controlled Schedule I Substances (DEA1222) | Rulemaking | 2024-02-12T10:29:05Z | 0b00006486330ce7 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2024-02-12T10:29:05Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Specific Listing for Three Currently Controlled Schedule I Substances (DEA1222)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486330ce7"} | single_get | ||||||||
| DEA-2023-0049 | DEA | Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I (DEA1006) | Rulemaking | 2023-12-12T10:13:43Z | 0b000064858c4370 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-12-12T10:13:43Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I (DEA1006)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064858c4370"} | single_get | ||||||||
| DEA-2023-0058 | DEA | Placement of Nine Specific Fentanyl Related Substances in Schedule I (DEA1036) | Rulemaking | 2023-12-07T08:20:24Z | 0b00006485946204 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-12-07T08:20:24Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of Nine Specific Fentanyl Related Substances in Schedule I (DEA1036)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485946204"} | single_get | ||||||||
| DEA-2023-0146 | DEA | Additions to Listing of Exempt Chemical Mixtures (DEA1118) | Rulemaking | 2023-11-28T08:25:33Z | 0b00006486128852 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-11-28T08:25:33Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Additions to Listing of Exempt Chemical Mixtures (DEA1118)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006486128852"} | single_get | ||||||||
| DEA-2023-0059 | DEA | Designation as List I Chemicals: Halides of 4-Anilinopiperidine (DEA1098) | Rulemaking | 2023-10-31T09:33:44Z | 0b00006485948761 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-10-31T09:33:44Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Designation as List I Chemicals: Halides of 4-Anilinopiperidine (DEA1098)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485948761"} | single_get | ||||||||
| DEA-2023-0106 | DEA | Dispensing of Narcotic Drugs to Relieve Acute Withdrawal Symptoms of Opioid Use Disorder (DEA702) | Rulemaking | 2023-09-22T15:24:15Z | 0b00006485e04d45 | 1117-AB73 | {"displayProperties": [], "keywords": null, "modifyDate": "2023-09-22T15:24:15Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Dispensing of Narcotic Drugs to Relieve Acute Withdrawal Symptoms of Opioid Use Disorder (DEA702)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB73", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485e04d45"} | single_get | ||||||||
| DEA-2019-0013 | DEA | Management of Quotas for Controlled Substances and List I Chemicals | Rulemaking | 2023-08-31T08:33:18Z | 0b000064840ecddb | 1117-AB49 | {"displayProperties": [], "keywords": null, "modifyDate": "2023-08-31T08:33:18Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Management of Quotas for Controlled Substances and List I Chemicals", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB49", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064840ecddb"} | single_get | ||||||||
| DEA-2021-0026 | DEA | Transfer of Electronic Prescriptions for Controlled Substances for Initial Filling | Rulemaking | 2023-07-27T17:35:24Z | 0b00006484e3d5e0 | 1117-AB64 | {"displayProperties": [], "keywords": null, "modifyDate": "2023-07-27T17:35:24Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Transfer of Electronic Prescriptions for Controlled Substances for Initial Filling", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB64", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484e3d5e0"} | single_get | ||||||||
| DEA-2020-0035 | DEA | Partial Filling of Prescriptions for Schedule II Controlled Substances | Rulemaking | 2023-07-21T08:48:17Z | 0b0000648498d6d9 | 1117-AB45 | {"displayProperties": [], "keywords": null, "modifyDate": "2023-07-21T08:48:17Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Partial Filling of Prescriptions for Schedule II Controlled Substances", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB45", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648498d6d9"} | single_get | ||||||||
| DEA-2020-0038 | DEA | Schedules of Controlled Substances: Placement of Brorphine in Schedule I | Rulemaking | 2023-07-19T11:16:28Z | 0b000064849c2716 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-07-19T11:16:28Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Brorphine in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064849c2716"} | single_get | ||||||||
| DEA-2020-0022 | DEA | Reporting of Theft or Significant Loss of Controlled Substances | Rulemaking | 2023-06-22T11:34:57Z | 0b000064847f5109 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-06-22T11:34:57Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Reporting of Theft or Significant Loss of Controlled Substances", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064847f5109"} | single_get | ||||||||
| DEA-2023-0056 | DEA | Specific Listing for Eutylone, a Currently Controlled Schedule I Substance (DEA1003) | Rulemaking | 2023-04-20T11:59:12Z | 0b0000648591cd29 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-04-20T11:59:12Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Specific Listing for Eutylone, a Currently Controlled Schedule I Substance (DEA1003)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648591cd29"} | single_get | ||||||||
| DEA-2022-0102 | DEA | Designation of 4-Piperidone as a List I Chemical (DEA951) | Rulemaking | 2023-04-14T08:25:52Z | 0b0000648532a5f2 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-04-14T08:25:52Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Designation of 4-Piperidone as a List I Chemical (DEA951)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648532a5f2"} | single_get | ||||||||
| DEA-2021-0013 | DEA | Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I | Rulemaking | 2023-01-03T10:35:25Z | 0b00006484d9d986 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2023-01-03T10:35:25Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484d9d986"} | single_get | ||||||||
| DEA-2022-0137 | DEA | Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023 | Rulemaking | 2022-12-02T09:49:04Z | 0b00006485511272 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-12-02T09:49:04Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485511272"} | single_get | ||||||||
| DEA-2020-0027 | DEA | Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration | Rulemaking | 2022-11-30T08:08:19Z | 0b000064848ac79e | 1117-AB36 | {"displayProperties": [], "keywords": null, "modifyDate": "2022-11-30T08:08:19Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB36", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064848ac79e"} | single_get | ||||||||
| DEA-2021-0012 | DEA | Schedules of Controlled Substances: Placement of Mesocarb in Schedule I | Rulemaking | 2022-11-22T08:27:38Z | 0b00006484c6c390 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-11-22T08:27:38Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Mesocarb in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484c6c390"} | single_get | ||||||||
| DEA-2021-0025 | DEA | Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control | Rulemaking | 2022-11-21T08:32:10Z | 0b00006484e16b15 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-11-21T08:32:10Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484e16b15"} | single_get | ||||||||
| DEA-2020-0015 | DEA | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I | Rulemaking | 2022-11-21T08:31:59Z | 0b000064846acf98 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-11-21T08:31:59Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Zipeprol in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064846acf98"} | single_get | ||||||||
| DEA-2021-0011 | DEA | Schedules of Controlled Substances: Placement of Amineptine in Schedule I | Rulemaking | 2022-11-17T08:07:18Z | 0b00006484c12765 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-11-17T08:07:18Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Amineptine in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484c12765"} | single_get | ||||||||
| DEA-2022-0134 | DEA | Specific Listing for 1-boc-4-AP, a Currently Controlled List I Chemical (DEA1046) | Rulemaking | 2022-11-14T08:34:19Z | 0b0000648549e00d | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-11-14T08:34:19Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Specific Listing for 1-boc-4-AP, a Currently Controlled List I Chemical (DEA1046)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648549e00d"} | single_get | ||||||||
| DEA-2022-0133 | DEA | Technical Correction to Regulation Regarding Registration Exception for Officials | Rulemaking | 2022-11-07T09:10:13Z | 0b000064854931e9 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-11-07T09:10:13Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Technical Correction to Regulation Regarding Registration Exception for Officials", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064854931e9"} | single_get | ||||||||
| DEA-2021-0014 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022 | Rulemaking | 2022-11-01T08:26:20Z | 0b00006484dc7d4f | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-11-01T08:26:20Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2022", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484dc7d4f"} | single_get | ||||||||
| DEA-2022-0025 | DEA | Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV | Rulemaking | 2022-09-30T08:21:23Z | 0b00006484fff734 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-09-30T08:21:23Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484fff734"} | single_get | ||||||||
| DEA-2022-0026 | DEA | Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I | Rulemaking | 2022-09-13T08:49:45Z | 0b0000648500a875 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-09-13T08:49:45Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648500a875"} | single_get | ||||||||
| DEA-2022-0001 | DEA | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I | Rulemaking | 2022-07-27T08:21:18Z | 0b00006484f21216 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-07-27T08:21:18Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484f21216"} | single_get | ||||||||
| DEA-2021-0010 | DEA | Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV | Rulemaking | 2022-06-24T08:22:18Z | 0b00006484b1ab60 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-06-24T08:22:18Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484b1ab60"} | single_get | ||||||||
| DEA-2022-0027 | DEA | Schedules of Controlled Substances: Exempted Prescription Products - Butalbital products | Rulemaking | 2022-06-07T08:46:48Z | 0b0000648500f7d4 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-06-07T08:46:48Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Exempted Prescription Products - Butalbital products", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648500f7d4"} | single_get | ||||||||
| DEA-2021-0030 | DEA | Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I | Rulemaking | 2022-06-06T09:58:53Z | 0b00006484ea7ed5 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-06-06T09:58:53Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484ea7ed5"} | single_get | ||||||||
| DEA-2019-0002 | DEA | Schedules of Controlled Substances: Placement of 5F-EDMBPINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I | Rulemaking | 2022-04-08T08:28:19Z | 0b00006483b714a4 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-04-08T08:28:19Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of 5F-EDMBPINACA,\n5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in\nSchedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006483b714a4"} | single_get | ||||||||
| DEA-2018-0002 | DEA | Implementation of the Provision of the Comprehensive Addiction and Recovery Act of 2016 Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder | Rulemaking | 2022-04-02T01:07:02Z | 0b00006482e4b773 | 1117-AB42 | {"displayProperties": [], "keywords": null, "modifyDate": "2022-04-02T01:07:02Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Implementation of the Provision of the Comprehensive Addiction and Recovery Act of 2016 Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB42", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006482e4b773"} | single_get | ||||||||
| DEA-2018-0009 | DEA | Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I | Rulemaking | 2022-04-02T01:07:02Z | 0b00006483254c72 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-04-02T01:07:02Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006483254c72"} | single_get | ||||||||
| DEA-2014-0005 | DEA | Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products from Schedule III to Schedule II | Rulemaking | 2022-03-22T11:18:07Z | 0b000064815b6cb3 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2022-03-22T11:18:07Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products from Schedule III to Schedule II", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064815b6cb3"} | single_get | ||||||||
| DEA-2018-0004 | DEA | Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U–47700 Into Schedule I (DEA-478) | Rulemaking | 2022-03-22T11:16:58Z | 0b0000648319a695 | Not Assigned | NA | {"displayProperties": [], "keywords": null, "modifyDate": "2022-03-22T11:16:58Z", "dkAbstract": null, "agencyId": "DEA", "program": "NA", "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances:\nPlacement of Butyryl Fentanyl and\nU\u201347700 Into Schedule I (DEA-478)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648319a695"} | single_get | |||||||
| DEA-2021-0024 | DEA | Adding Space Force to DEA Regulations | Rulemaking | 2021-12-13T15:38:43Z | 0b00006484e0408e | 1117-AB70 | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-13T15:38:43Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Adding Space Force to DEA Regulations", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB70", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006484e0408e"} | single_get | ||||||||
| DEA-2020-0036 | DEA | Supplier's Registration Number on the Single-Sheet DEA Form 222 | Rulemaking | 2021-12-13T15:35:55Z | 0b000064849af553 | 1117-AB61 | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-13T15:35:55Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Supplier's Registration Number on the Single-Sheet DEA Form 222", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB61", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064849af553"} | single_get | ||||||||
| DEA-2020-0005 | DEA | Registration Requirements for Narcotic Treatment Programs with Mobile Components | Rulemaking | 2021-12-13T15:33:40Z | 0b000064843b54e5 | 1117-AB43 | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-13T15:33:40Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Registration Requirements for Narcotic Treatment Programs with Mobile Components", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB43", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064843b54e5"} | single_get | ||||||||
| DEA-2013-0002 | DEA | Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV | Rulemaking | 2021-12-02T01:01:29Z | 0b000064812438ed | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:01:29Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064812438ed"} | single_get | ||||||||
| DEA-2013-0009 | DEA | Schedules of Controlled Substances: Placement of Perampanel into Schedule III | Rulemaking | 2021-12-02T01:01:29Z | 0b000064814577a1 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:01:29Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Perampanel into Schedule III", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064814577a1"} | single_get | ||||||||
| DEA-2013-0010 | DEA | Schedules of Controlled Substances: Placement of Tramadol into Schedule IV | Rulemaking | 2021-12-02T01:01:29Z | 0b0000648146f62c | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:01:29Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Placement of Tramadol into Schedule IV", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648146f62c"} | single_get | ||||||||
| DEA-2013-0011 | DEA | Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines into Schedule I | Rulemaking | 2021-12-02T01:01:29Z | 0b0000648147da34 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:01:29Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Temporary Placement of Three Synthetic \r\nPhenethylamines into Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648147da34"} | single_get | ||||||||
| DEA-2018-0006 | DEA | Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act, DEA-345 | Rulemaking | 2021-12-02T01:01:29Z | 0b0000648321a7cd | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:01:29Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act, DEA-345", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648321a7cd"} | single_get | ||||||||
| DEA-2019-0007 | DEA | Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control | Rulemaking | 2021-12-02T01:01:29Z | 0b00006483eaf996 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:01:29Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006483eaf996"} | single_get | ||||||||
| DEA-2019-0003 | DEA | Interlocutory Appeals in Administrative Hearings | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483c17ccc | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:00:59Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Interlocutory Appeals in Administrative\nHearings", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006483c17ccc"} | single_get | ||||||||
| DEA-2019-0004 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483c8ada8 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:00:59Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006483c8ada8"} | single_get | ||||||||
| DEA-2019-0009 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I | Rulemaking | 2021-12-02T01:00:59Z | 0b00006483f91d72 | Not Assigned | {"displayProperties": [], "keywords": null, "modifyDate": "2021-12-02T01:00:59Z", "dkAbstract": null, "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006483f91d72"} | single_get |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE dockets (
id TEXT PRIMARY KEY,
agency_id TEXT,
title TEXT,
docket_type TEXT,
last_modified TEXT,
object_id TEXT,
-- Rich fields from the per-docket single-GET object (16_backfill_dockets).
-- The docket LIST endpoint (02/expand_all) returns only the 6 base fields above,
-- so these are populated for 'single_get' rows and NULL for 'list_pull' rows.
rin TEXT,
dkabstract TEXT,
category TEXT,
subtype TEXT,
keywords TEXT,
program TEXT,
short_title TEXT,
effective_date TEXT,
organization TEXT, -- docket sponsoring org (single_get); load-bearing for lobbying docket->filing-org joins (spec 2026-07-04)
attrs_raw TEXT, -- verbatim data.attributes JSON (insurance: any field recoverable w/o refetch)
attr_source TEXT -- 'single_get' (full object) | 'list_pull' (6-field) | NULL (unfetched stub)
);
CREATE INDEX idx_dockets_agency ON dockets(agency_id);
CREATE INDEX idx_dockets_type ON dockets(docket_type);
CREATE INDEX idx_dockets_attr_source ON dockets(attr_source);